本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fortress Biotech Inc.

1.69
+0.0000
盘后1.690.00000.00%19:21 EDT
成交量:11.61万
成交额:19.28万
市值:4,991.22万
市盈率:-0.63
高:1.73
开:1.69
低:1.62
收:1.69
数据加载中...
2020/05/11

重要事件披露

8-K - Current report
2020/04/28

SEC问询函

CORRESP [Cover] - Correspondence
2020/03/23

重要事件披露

8-K - Current report
2020/03/16

重要事件披露

8-K - Current report
2020/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/02/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/01/27

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/12/31

重要事件披露

Current report, item 5.02
2019/11/26

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/26

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2019/11/22

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/08/19

重要事件披露

Current report, items 5.02 and 9.01
2019/08/09

重要事件披露

Current report, items 2.02 and 9.01
2019/08/09

员工持股计划

Securities to be offered to employees in employee benefit plans